Showing results (1-10 of 3,022) with videos related to
Sort By:
Pageof 303
Klinische Padiatrie|September 3, 1999
Recancostat compositum therapy does not prevent tumor progression in young cancer patientsU Bode, C Hasan, B Hülsmann, et al.Mycoses|February 21, 1998
Cyanotic Raynaud's phenomenon with conventional but not with liposomal amphotericin B: three case reportsB Zernikow, G Fleischhack, C Hasan, et al.Infection Control and Hospital Epidemiology|September 23, 2000
Surveillance for nosocomial and central line-related infections among pediatric hematology-oncology patientsA Simon, G Fleischhack, C Hasan, et al.Infection|October 13, 2006
Influence of prolonged use of intravenous administration sets in paediatric cancer patients on CVAD-related bloodstream infection rates and hospital resourcesA Simon, G Fleischhack, G Wiszniewsky, et al.Mycoses|July 9, 2002
Pancreatic toxicity after liposomal amphotericin BA Stuecklin-Utsch, C Hasan, U Bode, et al.British Journal of Haematology|February 13, 2001
Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor IIG Fleischhack, I Kambeck, D Cipic, et al.Intensive Care Medicine|May 13, 2008
Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancerG Fleischhack, D Cipic, J Juettner, et al.British Journal of Haematology|August 29, 1998
IDA-FLAG (idarubicin, fludarabine, cytarabine, G-CSF), an effective remission-induction therapy for poor-prognosis AML of childhood prior to allogeneic or autologous bone marrow transplantation: experiences of a phase II trialG Fleischhack, C Hasan, N Graf, et al.The Journal of Antimicrobial Chemotherapy|June 5, 2001
Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancerG Fleischhack, C Hartmann, A Simon, et al.Pediatric Hematology and Oncology|June 25, 2002
Intracranial manifestation of osteosarcomaS Hettmer, G Fleischhack, C Hasan, et al.Pageof 303